The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVesuvius Regulatory News (VSVS)

Share Price Information for Vesuvius (VSVS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 493.00
Bid: 490.00
Ask: 491.00
Change: 13.00 (2.71%)
Spread: 1.00 (0.204%)
Open: 491.50
High: 493.00
Low: 477.00
Prev. Close: 480.00
VSVS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Demerger Effective

19 Dec 2012 07:00

RNS Number : 8566T
Vesuvius plc
19 December 2012
 



19 December 2012

VESUVIUS PLC

Demerger update: Demerger effective

 

Vesuvius plc ("Vesuvius") is pleased to announce that the Demerger of its Performance Materials division to Alent plc has become effective.

Admission of the Alent Shares to the premium listing segment of the Official list and to trading on the London Stock Exchange's main market for listed securities, under the ticker ALNT, is expected to occur at 8.00 a.m. on Wednesday 19 December 2012. CREST accounts will be credited with Alent Shares at the same time and certificates in respect of Alent Shares will be despatched by 2 January 2013.

From 8.00 a.m. on Wednesday 19 December 2012 Vesuvius will trade on the London Stock Exchange's main market for listed securities under the ticker VSVS.

A detailed timetable of events is set out in the circular sent to Cookson Group plc shareholders dated 1 November 2012 (the "Circular").

Copies of the Circular are available for inspection during normal business hours on any business day at the offices of Linklaters LLP, One Silk Street, London EC2Y 8HQ, up to the date on which the Proposals set out in the Circular are fully implemented.

Capitalised terms used in this announcement have the meanings given to them in the Circular.

François Wanecq, Chief Executive of Vesuvius, stated:

"With the demerger process now completed, I am very pleased to be leading Vesuvius forward as a stand-alone, fully focused global leader in metal flow engineering. Despite the near-term macroeconomic challenges, Vesuvius is now well positioned to keep growing its addressable markets, to leverage its strong presence in developing regions, to improve margins and to deliver superior returns for its shareholders over the long term."

 

About Vesuvius

Vesuvius is a global leader in metal flow engineering, developing, manufacturing and marketing mission-critical ceramic consumable products and systems to demanding applications, primarily in the global steel and foundry industries. Vesuvius also supplies fabricated precious metals to the jewellery industry in Europe and has significant precious metals recycling operations.

About Alent

Alent is a leading global supplier of advanced surface treatment plating chemicals and electronics assembly materials. The principal end-market is global electronics production which accounts for approximately three-quarters of net sales value with the automotive and industrial end-markets the balance.

 

Contacts

Vesuvius Tel: +44 (0)20 7822 0000

François Wanecq, Chief Executive

Chris O'Shea, Chief Financial Officer

Rachel Fell, Company Secretary

Maddy Cox-Smith, Investor Relations Manager

MHP Communications Tel: +44 (0)20 3128 8100

John Olsen

Ian Payne

 

Vesuvius plc, 165 Fleet Street, London EC4A 2AE

Registered in England and Wales No. 8217766

 

www.vesuvius.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCTPBPTMBABBIT
Date   Source Headline
26th Mar 20215:54 pmRNSHolding(s) in Company
19th Mar 20215:52 pmRNSDirector/PDMR Shareholding
19th Mar 20215:49 pmRNSDirector/PDMR Shareholding
19th Mar 20213:54 pmRNSHolding(s) in Company
17th Mar 20215:07 pmRNSDirector/PDMR Shareholding
4th Mar 20217:00 amRNSFinal Results
12th Feb 20215:45 pmRNSHolding(s) in Company
17th Dec 202010:51 amRNSChange in Director's Details
11th Dec 202010:57 amRNSDirector/PDMR Shareholding
4th Dec 202010:14 amRNSHolding(s) in Company
30th Nov 20207:00 amRNSDirectorate Change
24th Nov 20203:07 pmRNSHolding(s) in Company
12th Nov 20207:00 amRNSTrading Update
22nd Oct 20209:50 amRNSHolding(s) in Company
20th Oct 20207:00 amRNSDividend Declaration
13th Oct 202011:30 amRNSTotal Voting Rights
6th Oct 202010:42 amRNSHolding(s) in Company
17th Sep 20207:00 amRNSDebt and Liquidity Update
2nd Sep 20208:31 amRNSDirector/PDMR Shareholding
30th Jul 20207:00 amRNSResults for the six months ended 30 June 2020
13th May 202012:44 pmRNSResult of AGM 2020
13th May 20207:00 amRNSAGM Trading Update
30th Apr 202011:28 amRNSChange in Director's Details
27th Apr 20206:13 pmRNSHolding(s) in Company
24th Apr 20205:13 pmRNSHolding(s) in Company
14th Apr 20205:37 pmRNSAnnual Financial Report 31 December 2019
9th Apr 20202:15 pmRNSTotal Voting Rights
6th Apr 20203:30 pmRNSStatement on COVID-19
2nd Apr 20209:45 amRNSHolding(s) in Company
24th Mar 20208:24 amRNSHolding(s) in Company
23rd Mar 20204:03 pmRNSDirector/PDMR Shareholding
13th Mar 202012:52 pmRNSDirector/PDMR Shareholding
13th Mar 202012:52 pmRNSDirector/PDMR Shareholding
11th Mar 202010:48 amRNSDirector/PDMR Shareholding
5th Mar 20204:45 pmRNSHolding(s) in Company
3rd Mar 20205:07 pmRNSHolding(s) in Company
27th Feb 20207:00 amRNSResults for the year ended 31 December 2019
20th Feb 20203:14 pmRNSHolding(s) in Company
3rd Feb 202011:53 amRNSChange in Director's Details
4th Dec 20194:24 pmRNSNon-executive Director Changes
15th Oct 20197:00 amRNSQ3 2019 Trading Update
2nd Oct 20195:36 pmRNSHolding(s) in Company
26th Sep 20196:00 pmRNSDirector/PDMR Shareholding
3rd Sep 201912:33 pmRNSTotal Voting Rights
26th Jul 201912:18 pmRNSHolding(s) in Company
25th Jul 20197:00 amRNSHalf-year Report
5th Jun 20191:20 pmRNSDirector/PDMR Shareholding
21st May 20194:03 pmRNSChange in Director's Details
15th May 20192:30 pmRNSResult of AGM
15th May 20197:00 amRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.